Literature DB >> 18375650

An examination of effect estimation in factorial and standardly-tailored designs.

Heather G Allore1, Terrence E Murphy.   

Abstract

BACKGROUND: Many clinical trials are designed to test an intervention arm against a control arm wherein all subjects are equally eligible for all interventional components. Factorial designs have extended this to test multiple intervention components and their interactions. A newer design referred to as a ;standardly-tailored' design, is a multicomponent interventional trial that applies individual interventional components to modify risk factors identified a priori and tests whether health outcomes differ between treatment arms. Standardly-tailored designs do not require that all subjects be eligible for every interventional component. Although standardly-tailored designs yield an estimate for the net effect of the multicomponent intervention, it has not yet been shown if they permit separate, unbiased estimation of individual component effects. The ability to estimate the most potent interventional components has direct bearing on conducting second stage translational research.
PURPOSE: We present statistical issues related to the estimation of individual component effects in trials of geriatric conditions using factorial and standardly-tailored designs. The medical community is interested in second stage translational research involving the transfer of results from a randomized clinical trial to a community setting. Before such research is undertaken, main effects and synergistic and or antagonistic interactions between them should be identified. Knowledge of the relative strength and direction of the effects of the individual components and their interactions facilitates the successful transfer of clinically significant findings and may potentially reduce the number of interventional components needed. Therefore the current inability of the standardly-tailored design to provide unbiased estimates of individual interventional components is a serious limitation in their applicability to second stage translational research.
METHODS: We discuss estimation of individual component effects from the family of factorial designs and this limitation for standardly-tailored designs. We use the phrase ;factorial designs' to describe full-factorial designs and their derivatives including the fractional factorial, partial factorial, incomplete factorial and modified reciprocal designs. We suggest two potential directions for designing multicomponent interventions to facilitate unbiased estimates of individual interventional components.
RESULTS: Full factorial designs and their variants are the most common multicomponent trial design described in the literature and differ meaningfully from standardly-tailored designs. Factorial and standardly-tailored designs result in similar estimates of net effect with different levels of precision. Unbiased estimation of individual component effects from a standardly-tailored design will require new methodology. LIMITATIONS: Although clinically relevant in geriatrics, previous applications of standardly-tailored designs have not provided unbiased estimates of the effects of individual interventional components. DISCUSSION: Future directions to estimate individual component effects from standardly-tailored designs include applying D-optimal designs and creating independent linear combinations of risk factors analogous to factor analysis.
CONCLUSION: Methods are needed to extract unbiased estimates of the effects of individual interventional components from standardly-tailored designs.

Mesh:

Year:  2008        PMID: 18375650      PMCID: PMC3477845          DOI: 10.1177/1740774508089278

Source DB:  PubMed          Journal:  Clin Trials        ISSN: 1740-7745            Impact factor:   2.486


  31 in total

1.  Design considerations for AIDS trials.

Authors:  D Byar
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1990

2.  Factorial and reciprocal control designs.

Authors:  D P Byar
Journal:  Stat Med       Date:  1990 Jan-Feb       Impact factor: 2.373

3.  Yale FICSIT: risk factor abatement strategy for fall prevention.

Authors:  M E Tinetti; D I Baker; P A Garrett; M Gottschalk; M L Koch; R I Horwitz
Journal:  J Am Geriatr Soc       Date:  1993-03       Impact factor: 5.562

4.  Incomplete factorial designs for randomized clinical trials.

Authors:  D P Byar; A M Herzberg; W Y Tan
Journal:  Stat Med       Date:  1993-09-15       Impact factor: 2.373

5.  Influence of gonadotropin-releasing hormone and timing of insemination relative to estrus on pregnancy rates of dairy cattle at first service.

Authors:  M O Mee; J S Stevenson; R K Scoby; Y Folman
Journal:  J Dairy Sci       Date:  1990-06       Impact factor: 4.034

6.  Prognostic implication of ST-segment resolution following primary percutaneous transluminal coronary angioplasty for ST-elevation acute myocardial infarction.

Authors:  A K Y Lee; N Sadick; A Ng; C Hsieh; D L Ross
Journal:  Intern Med J       Date:  2004 Sep-Oct       Impact factor: 2.048

Review 7.  Analysis and reporting of factorial trials: a systematic review.

Authors:  Finlay A McAlister; Sharon E Straus; David L Sackett; Douglas G Altman
Journal:  JAMA       Date:  2003-05-21       Impact factor: 56.272

8.  Linxian nutrition intervention trials. Design, methods, participant characteristics, and compliance.

Authors:  B Li; P R Taylor; J Y Li; S M Dawsey; W Wang; J A Tangrea; B Q Liu; A G Ershow; S F Zheng; J F Fraumeni
Journal:  Ann Epidemiol       Date:  1993-11       Impact factor: 3.797

9.  Central challenges facing the national clinical research enterprise.

Authors:  Nancy S Sung; William F Crowley; Myron Genel; Patricia Salber; Lewis Sandy; Louis M Sherwood; Stephen B Johnson; Veronica Catanese; Hugh Tilson; Kenneth Getz; Elaine L Larson; David Scheinberg; E Albert Reece; Harold Slavkin; Adrian Dobs; Jack Grebb; Rick A Martinez; Allan Korn; David Rimoin
Journal:  JAMA       Date:  2003-03-12       Impact factor: 56.272

10.  A multifactorial intervention to reduce the risk of falling among elderly people living in the community.

Authors:  M E Tinetti; D I Baker; G McAvay; E B Claus; P Garrett; M Gottschalk; M L Koch; K Trainor; R I Horwitz
Journal:  N Engl J Med       Date:  1994-09-29       Impact factor: 91.245

View more
  7 in total

1.  Gerontologic biostatistics: the statistical challenges of clinical research with older study participants.

Authors:  Peter H Van Ness; Peter A Charpentier; Edward H Ip; Xiaoyan Leng; Terrence E Murphy; Janet A Tooze; Heather G Allore
Journal:  J Am Geriatr Soc       Date:  2010-06-01       Impact factor: 5.562

Review 2.  Designing phenotyping studies for genetically engineered mice.

Authors:  C J Zeiss; J M Ward; H G Allore
Journal:  Vet Pathol       Date:  2011-09-19       Impact factor: 2.221

Review 3.  Comorbidity in older adults with cancer.

Authors:  Grant R Williams; Amy Mackenzie; Allison Magnuson; Rebecca Olin; Andrew Chapman; Supriya Mohile; Heather Allore; Mark R Somerfield; Valerie Targia; Martine Extermann; Harvey Jay Cohen; Arti Hurria; Holly Holmes
Journal:  J Geriatr Oncol       Date:  2015-12-22       Impact factor: 3.599

4.  Multidomain trials to prevent dementia: addressing methodological challenges.

Authors:  Manuel Montero-Odasso; G Y Zou; Nellie Kamkar; Howard H Feldman; Sylvie Belleville; Howard Chertkow; Haakon B Nygaard; Surim Son; Mark Speechley
Journal:  Alzheimers Res Ther       Date:  2022-07-11       Impact factor: 8.823

Review 5.  Geriatric assessment with management in cancer care: Current evidence and potential mechanisms for future research.

Authors:  Allison Magnuson; Heather Allore; Harvey Jay Cohen; Supriya G Mohile; Grant R Williams; Andrew Chapman; Martine Extermann; Rebecca L Olin; Valerie Targia; Amy Mackenzie; Holly M Holmes; Arti Hurria
Journal:  J Geriatr Oncol       Date:  2016-07-05       Impact factor: 3.599

Review 6.  Applying the Multiphase Optimization Strategy for the Development of Optimized Interventions in Palliative Care.

Authors:  Rachel D Wells; Kate Guastaferro; Andres Azuero; Christine Rini; Bailey A Hendricks; Chinara Dosse; Richard Taylor; Grant R Williams; Sally Engler; Charis Smith; Rebecca Sudore; Abby R Rosenberg; Marie A Bakitas; J Nicholas Dionne-Odom
Journal:  J Pain Symptom Manage       Date:  2020-11-28       Impact factor: 5.576

7.  Partial factorial trials: comparing methods for statistical analysis and economic evaluation.

Authors:  Helen A Dakin; Alastair M Gray; Graeme S MacLennan; Richard W Morris; David W Murray
Journal:  Trials       Date:  2018-08-16       Impact factor: 2.279

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.